drugset / Trial / NCT03805386

Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery

NCT03805386

Phase 2/3 Completed 65 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

We would like to evaluate and optimize opioid prescribing after minimally invasive hysterectomy. Currently, our standard prescribing is 150 oral morphine equivalents. However, recent studies show that half of the opioids prescribed are not used. We would like to include the patient in the decision making of the opioid prescribing. We have designed a randomized controlled trial to prescribe standard (150 oral morphine equivalents) or patient directed (less than or equal to 150 oral morphine equivalents) for pain control. We hypothesize that with patient input, there will be a higher utilization of the opioids prescribed. Also, we anticipate a lower number of opioids used overall. This study will help us optimize opioid prescribe and evaluate whether patient input can help in this important measure.

Timeline

Start
2019-01-15
Primary completion
2020-04-15
Completion
2020-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 5 mg Oral

Indications

No indication recorded.